GlassScriptPhysician profile
Jessica Stephens
NPI 1417375023
$4,842.74
in general payments reported to CMS, 2019-2025
14 companies · $649 in 2025
The $649 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,310 · 2021: $952 · 2022: $457 · 2023: $130 · 2024: $1,345 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,699 · Travel and Lodging: $416 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.44 |
| Travel and Lodging | $415.93 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,784.53 | 2020-2024 | |
| Stryker Corporation | $756.29 | 2021-2024 | 1788 |
| Medtronic, INC. | $417.56 | 2022-2025 | Interstim |
| Ethicon US, LLC | $360.36 | 2021-2025 | Stratafix, Enseal |
| Thd America, INC. | $158.63 | 2022-2024 | |
| Inspire Medical Systems, INC. | $129.78 | 2024-2025 | Inspire |
| Coopersurgical, INC. | $45.46 | 2023 | Wallach Cryosurgical Equipment |
| Sumitomo Pharma America, INC. | $39.15 | 2023 | Gemtesa |
| Axonics, INC. | $33.23 | 2024 | Axonics |
| Acell, INC. | $32.33 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.55 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $26.08 | 2025 | Exparel |
| Medtronic USA, INC. | $22.35 | 2020 | |
| Boston Scientific Corporation | $10.44 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.